Clinical trial
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
NCT00332033 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00332033 |
|---|---|
| Title | Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) |
| Official title | Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Uterine Leiomyoma, Fibroids |
| Intervention type | Drug |
| Interventions | Pirfenidone |
| Enrollment | 32 |
| Start date | May 25, 2006 |
| Completion | Feb 16, 2007 |
| First posted | Jun 1, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: